Kohjin Bio Co Ltd (177A)

Currency in JPY
788.00
+21.00(+2.74%)
Closed·
Advertisement
Trading near 52-week Low
177A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
765.00789.00
52 wk Range
765.001,882.00
Key Statistics
Bid/Ask
766.00 / 790.00
Prev. Close
788
Open
782
Day's Range
765-789
52 wk Range
765-1,882
Volume
4.1K
Average Volume (3m)
2.63K
1-Year Change
-49.1941%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
177A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Earnings

Latest Release
14/08/2026
EPS / Forecast
-8.20 / --
Revenue / Forecast
974M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 25.04
Dividend Yield
1.30%
Industry Median 2.48%
Annualised payout
10.00
Paid unevenly
5-Years Growth
-
Growth Streak

Compare 177A to Peers and Sector

Metrics to compare
177A
Peers
Sector
Relationship
P/E Ratio
31.5x−5.2x−0.3x
PEG Ratio
−0.38−0.070.00
Price/Book
0.7x2.9x2.6x
Price / LTM Sales
0.9x13.3x2.9x
Upside (Analyst Target)
-170.1%65.4%
Fair Value Upside
Unlock18.4%8.9%Unlock

Kohjin Bio Co., Ltd. manufactures and sells animal blood, serum, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics. It operates through Tissue Culture Business, Microbiology Business, and Cell Processing Business segments. The company offers tissue culture mediums for human cell culture, including human lymphocyte culture, hepatoblastoma-derived cell lines, adipose- derived stem cells, neural stem cells, fibroblast, vascular endothelial cells, and epidermal keratinocyte human cell cultures, as well as hair papilla. It also provides industrial cell cultures for CHO, hybridomas, mammalian, and insect cells; exosome production; cryopreservation solutions; cell dispersion reagents; adoptCell-NK kits, and bags and other materials. In addition, the company offers culture medium for clinical bacteriological testing, and food and environmental testing, drug resistance testing, and staining solutions. Further, it offers RepliSkin 3D, a three-dimensional artificial human skin; cell culture processing contract service; culture related equipment for regenerative medicine and microorganisms; immunochromatographic assay kit; I-block series; and human blood, serum, and plasma. Additionally, it engages in the sale of medical equipment and import and export of products and raw materials. The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989. Kohjin Bio Co., Ltd. was incorporated in 1981 and is headquartered in Sakado, Japan.

Employees
176
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.90K0.21%8.36M
Other Institutional Investors
1.51M29.47%1.16B
Public Companies & Retail Investors
3.59M70.32%2.76B
Total
5.11M100.00%3.92B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
The Goldman Sachs Group, Inc.8.21%419,890322,056
IQ EQ Fund Management (Singapore) Private Limited7.11%363,300278,651

FAQ

What Is the Kohjin Bio (Tokyo: 177A) Share Price Today?

The Kohjin Bio stock price today is 788.00 JPY.

What Stock Exchange Does Kohjin Bio (177A) Trade On?

Kohjin Bio is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Kohjin Bio?

The stock symbol (also called a 'ticker') for Kohjin Bio is "177A."

Does Kohjin Bio Pay Dividends? What’s The Current 177A Dividend Yield?

Yes, 177A Pays Dividends to its Shareholders. The current Kohjin Bio dividend yield is 1.3%%.

What Is the Current Kohjin Bio Market Capitalisation?

As of today, Kohjin Bio (Tokyo: 177A) market cap is 4.03B JPY.

What Is Kohjin Bio's (177A) Earnings Per Share (TTM)?

The Kohjin Bio EPS is currently 25.04 (Trailing Twelve Months).

When Is the Next Kohjin Bio Earnings Date?

Kohjin Bio's next earnings report will be released on 13/11/2026.

Is 177A a Buy or Sell From a Technical Analyst Perspective?

Based on today's Kohjin Bio moving averages and other technical indicators, the daily buy/sell signal for 177A stock is Strong Sell.

How Many Times Has Kohjin Bio Stock Split?

Kohjin Bio has split 0 times. (See the 177A stock split history page for full effective split date and price information.)

How Many Employees Does Kohjin Bio Have?

Kohjin Bio has 176 employees, based on their latest Companies House report.

What is the current trading status of Kohjin Bio (Tokyo: 177A)?

As of 26/10/2026, Kohjin Bio (177A) is trading at a share price of 788.00 JPY, with a previous close of 788.00 JPY. The stock has fluctuated within a day range of 765.00 JPY to 789.00 JPY, while its 52-week range spans from 765.00 JPY to 1,882.00 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.